LighthouseHow Does Awareness of Biomarkers Compare to Prevalence?We compared awareness in oncologists of selected biomarkers to the prevalence of actionable oncogenic mutations across cancers.
LighthouseDoes Every Cancer Patient Get Next Generation Sequencing?NGS is useful for diagnosis and prognosis but also for treatment decisions and resistance monitoring yet it is not consistently used.